Filing Details
- Accession Number:
- 0000904454-22-000633
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-15 17:09:43
- Reporting Period:
- 2022-12-13
- Accepted Time:
- 2022-12-15 17:09:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1590560 | Uniqure N.v. | QURE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1692444 | Paula Soteropoulos | C/O Uniqure N.v. Paasheuvelweg 25A Amsterdam P7 11058BP | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2022-12-13 | 3,000 | $5.37 | 19,382 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2022-12-13 | 3,000 | $23.45 | 16,382 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2022-12-14 | 3,800 | $0.00 | 20,182 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2022-12-14 | 3,800 | $23.43 | 16,382 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2022-12-13 | 3,000 | $0.00 | 3,000 | $5.37 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2022-12-14 | 3,800 | $0.00 | 3,800 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,000 | 2018-01-27 | 2027-01-27 | No | 4 | M | Direct |
| 0 | 2023-06-06 | No | 4 | M | Direct |
Footnotes
- The reported transactions were effected pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- The Stock Option exercise price was EUR 10.10 per share or $10.69, as converted, based on the exchange rate at on December 13, 2022 of EUR 1 to $1.058.
- The Stock Option was granted on June 6, 2013 and vested 25% after one year, with the remainder vesting in weekly installments over a two year period ending on June 10, 2016.
Billionaire Hedge Funds
